LifeStance Health Group, Inc. (LFST): who owns it and who trades it
As of Nov 16, 2026, LFST insiders reported 38 open-market sales worth $1.4B and no purchases in the last 12 months, with 3% of the sale value made under pre-set 10b5-1 plans. The largest seller was Tpg Gp A, Llc (10% owner), with $1.2B. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling LifeStance Health Group
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns LFST
285 funds and institutions reported LFST shares worth $4.1B at the end of Q2 2026, about 98% of the company. The largest holder is Tpg Gp A, LLC with 28.8%.
Funds and institutions (13F) 98%Everyone else 2%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Tpg Gp A, LLC | 111.74M | 28.81% | $1.2B | -20% |
| FMR LLC (Fidelity) | 58.25M | 15.02% | $624M | -1% |
| BlackRock, Inc. | 36.35M | 9.37% | $389M | +100% |
| Summit Partners L P | 23.31M | 6.01% | $250M | -20% |
| Vanguard Portfolio Management LLC | 13.96M | 3.60% | $150M | +44% |
| Jennison Associates LLC | 12.08M | 3.11% | $129M | +18% |
| Dimensional Fund Advisors LP | 11.43M | 2.95% | $122M | +10% |
| Vanguard Capital Management LLC | 9.74M | 2.51% | $104M | +23% |
| State Street Corp | 8.23M | 2.12% | $88.1M | +101% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.95M | 1.53% | $63.7M | -2% |
| Geode Capital Management, LLC | 5.59M | 1.44% | $59.9M | +18% |
| Morgan Stanley | 5.02M | 1.29% | $53.8M | +46% |
| Principal Financial Group Inc | 4.00M | 1.03% | $42.8M | +30% |
| Millennium Management LLC | 3.61M | 0.93% | $38.6M | +90% |
| First Eagle Investment Management, LLC | 3.13M | 0.81% | $33.5M | +94% |
| Nuveen, LLC | 3.06M | 0.79% | $32.8M | +38% |
| Integral Health Asset Management, LLC | 3.00M | 0.77% | $32.1M | -30% |
| Wellington Management Group LLP | 2.88M | 0.74% | $30.9M | – |
| T. Rowe Price Associates | 2.77M | 0.71% | $29.7M | +1751% |
| Northern Trust Corp | 2.14M | 0.55% | $22.9M | +39% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, LFST insiders reported $0 of open-market purchases and $1.4B of sales. 3% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Kenneth A Burdick | Director | Sale | 159,624 | $14.31 | $2.3M | Form 4 |
| Nov 12, 2026 | Tpg Gp A, Llc +2 | 10% owner | Sale | 37.23M | $13.02 | $485M | Form 4 |
| Nov 11, 2026 | Lisa K Miller | Chief Operating Officer | Sale plan | 14,663 | $14.68 | $215K | Form 4 |
| Nov 10, 2026 | Ryan Pardo | See Remarks | Sale plan | 587,920 | $14.58 | $8.6M | Form 4 |
| Nov 10, 2026 | Ryan Pardo | See Remarks | Sale plan | 2.22M | $14.58 | $32.3M | Form 4 |
| Nov 10, 2026 | Kenneth A Burdick | Director | Sale | 75,000 | $14.60 | $1.1M | Form 4 |
| Nov 9, 2026 | Kenneth A Burdick | Director | Sale | 66,589 | $14.41 | $960K | Form 4 |
| Sep 11, 2026 | Tpg Gp A, Llc +2 | 10% owner | Sale | 18.41M | $12.29 | $226M | Form 4 |
| Sep 2, 2026 | Vukasin Paunovich | Chief Technology Officer | Sale | 42,067 | $12.87 | $541K | Form 4 |
| Aug 14, 2026 | Teresa DeLuca | Director | Sale | 7,500 | $12.68 | $95.1K | Form 4 |
| Aug 13, 2026 | Teresa DeLuca | Director | Sale | 20,441 | $12.23 | $250K | Form 4 |
| Aug 11, 2026 | Kenneth A Burdick | Director | Sale | 500,000 | $11.51 | $5.8M | Form 4 |
| Aug 10, 2026 | Vukasin Paunovich | Chief Technology Officer | Sale | 44,394 | $10.85 | $482K | Form 4 |
| Aug 10, 2026 | Tpg Gp A, Llc +2 | 10% owner | Sale | 13.64M | $10.62 | $145M | Form 4 |
| Aug 10, 2026 | Lisa K Miller | Chief Operating Officer | Sale | 47,912 | $10.85 | $520K | Form 4 |
| Jun 26, 2026 | Robert Bessler | Director | Sale | 447,169 | $10.13 | $4.5M | Form 4 |
| Jun 26, 2026 | Robert Bessler | Director | Sale | 447,168 | $10.13 | $4.5M | Form 4 |
| May 12, 2026 | Robert Bessler | Director | Sale | 287,517 | $8.02 | $2.3M | Form 4 |
| May 12, 2026 | Eric Shuey | Director | Sale | 243,362 | $8.02 | $2M | Form 4 |
| May 12, 2026 | Darren M. Black | Director | Sale | 5.90M | $8.02 | $47.3M | Form 4 |
| May 12, 2026 | Tpg Gp A, Llc +2 | 10% owner | Sale | 28.28M | $8.02 | $227M | Form 4 |
| May 7, 2026 | Robert Bessler | Director | Sale | 37,500 | $8.55 | $321K | Form 4 |
| Apr 24, 2026 | Robert Bessler | Director | Sale | 31,073 | $7.05 | $219K | Form 4 |
| Apr 24, 2026 | Robert Bessler | Director | Sale | 31,074 | $7.05 | $219K | Form 4 |
| Apr 23, 2026 | Robert Bessler | Director | Sale | 3,876 | $7.00 | $27.1K | Form 4 |
| Apr 21, 2026 | Robert Bessler | Director | Sale | 2,551 | $7.01 | $17.9K | Form 4 |
| Apr 21, 2026 | Robert Bessler | Director | Sale | 2,550 | $7.01 | $17.9K | Form 4 |
| Mar 2, 2026 | Tpg Gp A, Llc +2 | 10% owner | Sale | 20.69M | $7.01 | $145M | Form 4 |
| Mar 2, 2026 | Darren M. Black | Director | Sale | 4.31M | $7.01 | $30.2M | Form 4 |
| Dec 22, 2025 | Robert Bessler | Director | Sale | 851 | $7.04 | $6K | Form 4 |
| Dec 22, 2025 | Robert Bessler | Director | Sale | 850 | $7.04 | $6K | Form 4 |
| Dec 19, 2025 | Robert Bessler | Director | Sale | 59,971 | $7.04 | $422K | Form 4 |
| Dec 18, 2025 | Robert Bessler | Director | Sale | 3,221 | $7.00 | $22.5K | Form 4 |
| Dec 17, 2025 | Ann Varanakis | Chief People Officer | Sale | 50,000 | $6.90 | $345K | Form 4 |
| Dec 15, 2025 | Robert Bessler | Director | Sale | 6,185 | $7.00 | $43.3K | Form 4 |
| Dec 15, 2025 | Robert Bessler | Director | Sale | 6,186 | $7.00 | $43.3K | Form 4 |
| Dec 12, 2025 | Robert Bessler | Director | Sale | 39,815 | $7.01 | $279K | Form 4 |
| Nov 21, 2025 | Lisa K Miller | See Remarks | Sale | 57,240 | $6.43 | $368K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Tpg Gp A, Llc | 10% owner | – | $1.2B | Nov 12, 2026 |
| Darren M. Black | Director | – | $77.6M | May 12, 2026 |
| Ryan Pardo | See Remarks | – | $40.9M | Nov 10, 2026 |
| Robert Bessler | Director | – | $13M | Jun 26, 2026 |
| Kenneth A Burdick | Director | – | $10.1M | Nov 12, 2026 |
| Eric Shuey | Director | – | $2M | May 12, 2026 |
| Lisa K Miller | See Remarks | – | $1.1M | Nov 11, 2026 |
| Vukasin Paunovich | Chief Technology Officer | – | $1M | Sep 2, 2026 |
| Teresa DeLuca | Director | – | $345K | Aug 14, 2026 |
| Ann Varanakis | Chief People Officer | – | $345K | Dec 17, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LFST short interest
Low short interest. 3.6% of LFST shares are sold short: about 1 share in 28. Over the last 12 reports the number of shares short went up 59%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 13.66M LFST shares were sold short, 3.6% of the shares outstanding, down 0.8% from the report before. At the average daily volume of 3.12M shares, buying them all back would take about 4.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 13.66M | 3.59% | -1% | 3.12M | 4.4 |
| Oct 15, 2026 | 13.77M | 3.60% | -11% | 2.88M | 4.8 |
| Sep 30, 2026 | 15.51M | 4.06% | -5% | 6.08M | 2.5 |
| Sep 15, 2026 | 16.26M | 4.26% | +19% | 5.29M | 3.1 |
| Aug 31, 2026 | 13.62M | 3.57% | +19% | 3.21M | 4.2 |
| Aug 14, 2026 | 11.42M | 2.99% | +19% | 5.69M | 2.0 |
| Jul 31, 2026 | 9.57M | 2.51% | +1% | 2.73M | 3.5 |
| Jul 15, 2026 | 9.46M | 2.44% | -2% | 3.54M | 2.7 |
| Jun 30, 2026 | 9.63M | 2.48% | +20% | 4.89M | 2.0 |
| Jun 15, 2026 | 8.02M | 2.07% | +1% | 2.45M | 3.3 |
| May 29, 2026 | 7.95M | 2.05% | -7% | 2.93M | 2.7 |
| May 15, 2026 | 8.58M | 2.21% | +24% | 7.91M | 1.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
LifeStance Health Group company events
LifeStance Health Group filed 11 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Oct 16, 2026LeadershipTeresa DeLuca, M.D., notified the LifeStance Health Group, Inc. board of directors of her resignation from the Board and all of its committees, effective as of December 31, 2026. Filing
- Sep 11, 2026AnnouncementLifeStance Health Group, Inc. entered into an Underwriting Agreement by and among the Company, Barclays Capital Inc., and the selling stockholders named in Schedule II thereto, relating to the underwritten offering of 22,250,000 shares of the Company’s common stock, par value $0.01 per share… Filing
- Aug 6, 2026AnnouncementThe Board of Directors of the Company approved a share repurchase program, which authorizes the Company to repurchase up to $100 million of the Company's outstanding shares of common stock. Filing
- Jul 7, 2026LeadershipJeffrey Rhodes notified the LifeStance Health Group, Inc. board of directors of his resignation from the Board and all of its committees, effective immediately. Filing
- Jun 4, 2026VoteReported shareholder vote results. Filing
- May 12, 2026AnnouncementLifeStance Health Group, Inc. entered into an Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, and the selling stockholders named in Schedule II thereto, relating to the underwritten offering of 35,000,000 shares of the Company’s common stock, par value $0.01 per share… Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 11, 2026LeadershipLifeStance Health Group, Inc. promoted Lisa Miller, age 52, to serve as the Company’s Chief Operating Officer and Principal Operating Officer. Filing
- Mar 2, 2026AnnouncementLifeStance Health Group, Inc. entered into an Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, and the selling stockholders named in Schedule II thereto, relating to the underwritten offering of 25,000,000 shares of the Company’s common stock, par value $0.01 per share… Filing
- Feb 25, 2026LeadershipKenneth Burdick, Executive Chairman of the Board of Directors of the Company announced his planned transition to non-executive Chairman of the Board effective March 16, 2026. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
LifeStance Health Group financials
Famous investors that hold LFST
4 of the 50 well-known investors we track reported holding LFST in their latest 13F filing. The largest position is Jim Simons's, worth $17.3M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.44M | $17.3M | 0.0% | +50% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 966,164 | $11.6M | 0.0% | +1372% |
| Israel Englander · Millennium Management | Q3 2026 | 908,851 | $10.9M | 0.0% | -75% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 628,185 | $7.6M | 0.0% | +22% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named LFST in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | TPG GP A, LLC | 13G/A | 11.2% |
| Nov 16, 2026 | TPG GP A, LLC | 13G/A | 11.2% |
| Nov 13, 2026 | Summit Partners, L.P. | 13G/A | 4.4% |
| Nov 13, 2026 | Summit Partners, L.P. | 13G/A | 4.4% |
| Oct 5, 2026 | BlackRock, Inc. | 13G/A | 10.1% |
| Oct 5, 2026 | BlackRock, Inc. | 13G/A | 10.1% |
Questions about LifeStance Health Group, Inc. (LFST) stock
Who owns the most LFST stock?
The largest reported owner of LifeStance Health Group, Inc. (LFST) is Tpg Gp A, LLC, with 28.8% of the company. In total, 285 funds and institutions reported holding LFST at the end of Q2 2026, together about 98% of the shares. See the largest owners.
Are LFST insiders buying or selling?
In the last 12 months, LFST insiders reported no open-market purchases and 38 sales worth $1.4B. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in LFST?
As of Oct 30, 2026, 13.66M LFST shares were sold short, 3.6% of the shares outstanding, down 0.8% from the report before. At the average daily volume of 3.12M shares, buying them all back would take about 4.4 trading days (days to cover). See the history.
Which famous investors hold LFST?
4 of the 50 well-known investors we track reported LFST in their latest 13F filing, including Jim Simons, Steve Cohen, Israel Englander. The largest position is worth $17.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.